BUDENOFALK budesonide 3 mg enteric capsules Australia - English - Department of Health (Therapeutic Goods Administration)

budenofalk budesonide 3 mg enteric capsules

dr falk pharma australia pty ltd - budesonide, quantity: 3 mg - capsule, enteric - excipient ingredients: sodium lauryl sulfate; purified talc; lactose monohydrate; ammonio methacrylate copolymer; methacrylic acid copolymer; titanium dioxide; erythrosine; iron oxide red; gelatin; iron oxide black; povidone; triethyl citrate; maize starch; sucrose - budenofalk enteric capsules are indicated for: induction of remission in patients with mild to moderately active crohn's disease affecting the ileum and/or the ascending colon (see clinical trials).

BUDENOFALK budesonide foam 2 mg cans Australia - English - Department of Health (Therapeutic Goods Administration)

budenofalk budesonide foam 2 mg cans

dr falk pharma australia pty ltd - budesonide, quantity: 2 mg - foam - excipient ingredients: propylene glycol; purified water; emulsifying wax; cetyl alcohol; citric acid monohydrate; disodium edetate; butane; isobutane; propane; steareth-10 - budenofalk foam is indicated in the treatment of active rectal and rectosigmoid disease in ulcerative colitis.

Budenofalk 3 mg gastro-resistant capsules Ireland - English - HPRA (Health Products Regulatory Authority)

budenofalk 3 mg gastro-resistant capsules

dr. falk pharma gmbh - budesonide - gastro-resistant capsule, hard - 3 milligram(s) - corticosteroids acting locally; budesonide

Budenofalk 2mg/dose rectal foam Ireland - English - HPRA (Health Products Regulatory Authority)

budenofalk 2mg/dose rectal foam

dr. falk pharma gmbh - budesonide - rectal foam - 2 milligram(s)/dose - corticosteroids acting locally; budesonide

Budenofalk® 9mg gastro-resistant granules Ireland - English - HPRA (Health Products Regulatory Authority)

budenofalk® 9mg gastro-resistant granules

dr. falk pharma gmbh - budesonide - gastro-resistant granules - 9 milligram(s) - corticosteroids acting locally; budesonide